CMS Extends GENEROUS Model Drug Pricing Deadline to April 2026
Key Takeaways
- The Centers for Medicare & Medicaid Services (CMS) has extended the Generating Cost Reductions for U.S. Medicaid (GENEROUS) Model manufacturer application deadline from March 31, 2026, to April 30, 2026.
- The Innovation Center model allows participating state Medicaid programs to purchase selected drugs at prices aligned with certain international benchmarks.
- The final manufacturer participation deadline remains June 30, 2026, with additional engagement opportunities planned this spring.
CMS has extended the application deadline for prescription drug manufacturers to participate in the GENEROUS Model. The extension, announced by CMS, moves the deadline from March 31, 2026, to April 30, 2026, offering manufacturers additional time to apply to the Innovation Center initiative aimed at lowering Medicaid drug spending.
The GENEROUS Model, announced in November 2025, is a CMS Innovation Center initiative designed to reduce prescription drug costs in Medicaid while improving quality of care and health outcomes through expanded access to critical medications.
Under the model, participating state Medicaid programs will be able to purchase drugs included in the pilot at prices aligned with those paid in select other countries. CMS stated that this structure is intended to help states secure fairer and more competitive pricing for medications covered under Medicaid.
“Based on feedback from drug manufacturers, CMS has decided to give interested companies additional time to apply for the GENEROUS Model,” said CMS Administrator Dr Mehmet Oz. “We are committed to partnering with states and manufacturers to drive down drug prices and ensure that the most vulnerable Americans have access to life-saving medications.”
CMS Innovation Center Director Abe Sutton added that the extension is designed in part to accommodate smaller stakeholders. “Extending this deadline will allow for small and midsize manufacturers to participate and lower costs to the Medicaid program, providing more flexibility for state budgets and ensure that people who depend on Medicaid continue to access the care they need,” Sutton said.
CMS will begin scheduling meetings with interested manufacturers starting April 1, 2026. A manufacturer town hall focused on operational and methodological details is planned for Spring 2026. The final deadline for manufacturer participation remains June 30, 2026.
Clinical Implications
For state Medicaid programs, the GENEROUS Model represents a potential mechanism to manage rising prescription drug expenditures through international price alignment. By enabling participating states to access pricing comparable to that in select other countries, CMS aims to enhance purchasing leverage and improve budget predictability.
For payers and managed care organizations, the model may influence formulary strategy, contracting approaches, and negotiations with manufacturers. Expanded manufacturer participation—particularly among small and midsize companies—could broaden the range of drugs available under the model and increase competition.
From a patient care perspective, CMS frames the initiative as a tool to maintain or improve access to life-saving medications for Medicaid beneficiaries. The agency links cost reductions with improved sustainability of state Medicaid programs, potentially supporting long-term coverage stability.
Conclusion
By extending the GENEROUS Model application deadline to April 30, 2026, CMS aims to increase manufacturer participation and strengthen Medicaid drug pricing reform efforts. With additional stakeholder engagement planned this spring and a June 30 final deadline, the model continues to evolve as a key federal strategy to address Medicaid prescription drug costs.
Reference
Centers for Medicare & Medicaid Services. CMS to lower drug costs and improve care by extending deadline for GENEROUS model application. March 2, 2026. Accessed March 3, 2026. https://www.cms.gov/newsroom/press-releases/cms-lower-drug-costs-improve-care-extending-deadline-generous-model-application
